Pre-Existing Interstitial Lung Abnormalities Are Independent Risk Factors for Interstitial Lung Disease during Durvalumab Treatment after Chemoradiotherapy in Patients with Locally Advanced Non-Small-Cell Lung Cancer
- DOI
- 10.3390/cancers14246236
- Published
- 2022-12-17
- Container
- Cancers
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/cancers14246236,
title = {Pre-Existing Interstitial Lung Abnormalities Are Independent Risk Factors for Interstitial Lung Disease during Durvalumab Treatment after Chemoradiotherapy in Patients with Locally Advanced Non-Small-Cell Lung Cancer},
author = {Wakako Daido and Takeshi Masuda and Nobuki Imano and Naoko Matsumoto and Kosuke Hamai and Yasuo Iwamoto and Yusuke Takayama and Sayaka Ueno and Masahiko Sumii and Hiroyasu Shoda and Nobuhisa Ishikawa and Masahiro Yamasaki and Yoshifumi Nishimura and Shigeo Kawase and Naoki Shiota and Yoshikazu Awaya and Tomoko Suzuki and Soichi Kitaguchi and Kazunori Fujitaka and Yasushi Nagata and Noboru Hattori},
year = {2022},
journal = {Cancers},
doi = {10.3390/cancers14246236},
url = {https://doi.org/10.3390/cancers14246236}
}RIS
TY - JOUR TI - Pre-Existing Interstitial Lung Abnormalities Are Independent Risk Factors for Interstitial Lung Disease during Durvalumab Treatment after Chemoradiotherapy in Patients with Locally Advanced Non-Small-Cell Lung Cancer AU - Wakako Daido AU - Takeshi Masuda AU - Nobuki Imano AU - Naoko Matsumoto AU - Kosuke Hamai AU - Yasuo Iwamoto AU - Yusuke Takayama AU - Sayaka Ueno AU - Masahiko Sumii AU - Hiroyasu Shoda AU - Nobuhisa Ishikawa AU - Masahiro Yamasaki AU - Yoshifumi Nishimura AU - Shigeo Kawase AU - Naoki Shiota AU - Yoshikazu Awaya AU - Tomoko Suzuki AU - Soichi Kitaguchi AU - Kazunori Fujitaka AU - Yasushi Nagata AU - Noboru Hattori PY - 2022 JO - Cancers DO - 10.3390/cancers14246236 UR - https://doi.org/10.3390/cancers14246236 ER -
APA
Daido, W., Masuda, T., Imano, N., Matsumoto, N., Hamai, K., Iwamoto, Y., Takayama, Y., Ueno, S., Sumii, M., Shoda, H., Ishikawa, N., Yamasaki, M., Nishimura, Y., Kawase, S., Shiota, N., Awaya, Y., Suzuki, T., Kitaguchi, S., Fujitaka, K., Nagata, Y., & Hattori, N. (2022). Pre-Existing Interstitial Lung Abnormalities Are Independent Risk Factors for Interstitial Lung Disease during Durvalumab Treatment after Chemoradiotherapy in Patients with Locally Advanced Non-Small-Cell Lung Cancer. Cancers. https://doi.org/10.3390/cancers14246236
Source records
- crossref · retrieved 2026-09-26T22:56:26.707Z